Journal
JOURNAL OF CLINICAL MEDICINE
Volume 10, Issue 13, Pages -Publisher
MDPI
DOI: 10.3390/jcm10133002
Keywords
osteoporosis; treatment gap; pharmacological treatment; epidemiology; review; fracture; glucocorticoid
Categories
Funding
- European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [860898]
- Erasmus MC fellowship grant
Ask authors/readers for more resources
Osteoporosis is a bone disease that increases the risk of fracture due to low bone mineral density and deterioration of bone architecture. Despite a variety of treatment options, there is still a large group of patients being left undertreated or untreated, known as the "treatment gap." Rare side effects of medications and insufficient knowledge about treatment benefits contribute to this gap.
Worldwide, there are millions of people who have been diagnosed with osteoporosis, a bone disease that increases the risk of fracture due to low bone mineral density and deterioration of bone architecture. In the US alone, there are approximately ten million men and women diagnosed with osteoporosis and this number is still growing. Diagnosis is made by measuring bone mineral density. Medications used for the treatment of osteoporosis are bisphosphonates, denosumab, raloxifene, and teriparatide. Recently, romosozumab has been added as well. In recent years, a number of advances have been made in the field of diagnostic methods and the diverse treatment options for osteoporosis. Despite these advances and a growing incidence of osteoporosis, there is a large group being left undertreated or even untreated. This group of the under/untreated has been called the treatment gap. Concerns regarding rare side effects of the medications, such as osteonecrosis of the jaw, have been reported to be one of the many causes for the treatment gap. Also, this group seems not to be sufficiently informed of the major benefits of the treatment and the diversity in treatment options. Knowledge of these could be very helpful in improving compliance and hopefully reducing the gap. In this paper, we summarize recent evidence regarding the efficacy of the various treatment options, potential side effects, and the overall benefit of treatment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available